Cerebrovascular and neurological perspectives on adrenoceptor and calcium channel modulating pharmacotherapies |
| |
| Authors: | Michael M Gezalian Luigi Mangiacotti Padmesh Rajput Nicklaus Sparrow Konrad Schlick Shouri Lahiri |
| |
| Institution: | 1.Departments of Neurology and Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA;2.Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA;3.Departments of Neurology, Neurosurgery, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA |
| |
| Abstract: | Adrenoceptor and calcium channel modulating medications are widely used in clinical practice for acute neurological and systemic conditions. It is generally assumed that the cerebrovascular effects of these drugs mirror that of their systemic effects – and this is reflected in how these medications are currently used in clinical practice. However, recent research suggests that there are distinct cerebrovascular-specific effects of these medications that are related to the unique characteristics of the cerebrovascular anatomy including the regional heterogeneity in density and distribution of adrenoceptor subtypes and calcium channels along the cerebrovasculature. In this review, we critically evaluate existing basic science and clinical research to discuss known and putative interactions between adrenoceptor and calcium channel modulating pharmacotherapies, the neurovascular unit, and cerebrovascular anatomy. In doing so, we provide a rationale for selecting vasoactive medications based on lesion location and lay a foundation for future investigations that will define neuroprotective paradigms of adrenoceptor and calcium channel modulating therapies to improve neurological outcomes in acute neurological and systemic disorders. |
| |
| Keywords: | Adrenergic receptors calcium channel calcium channel blocker neurovascular unit vasopressor |
|
|
